Joint Formulary & PAD

Betahistine hydrochloride - Tinnitus

You are here : Home > Formulary Search > Betahistine hydrochloride - Tinnitus

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Betahistine hydrochloride
Indication :
Tinnitus
Group Name :
Keywords :
Ringing in ears
Brand Names Include :
Serc
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

03 Jun 20 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Surrey & North West Sussex Area Prescribing Committee (APC) do not recommend the use of betahistine for Tinnitus. This is in line with recommendations made by NICE (NG155) Tinnitus: assessment and management (NG155) NICE states:

'Do not offer' betahistine for tinnitus

Other Indications

Below are listed other indications that Betahistine hydrochloride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Tinnitus.

  • No records returned.